date:Sep 06, 2013
k global reach, as the company seeks to make its consumer health business more focused.
JP Morgan (JPM.N) and Greenhill (GHL.N) are acting for GSK on the disposal.
The sale had been expected to attract interest from drinks companies and private equity houses, although Suntory was early on seen as a likely front-runner given its desire to build up its European drinks business after buying Orangina Schweppes for more than 300 billion yen ($3.0 billion) in 2009.
Officials at GSK and Suntory decl